Vanguard Group’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.86M | Buy |
|
|||||
|
2025
Q1 | $4.58M | Sell |
|
|||||
|
2024
Q4 | $6.16M | Sell |
|
|||||
|
2024
Q3 | $9.2M | Buy |
|
|||||
|
2024
Q2 | $7.08M | Buy |
|
|||||
|
2024
Q1 | $4.31M | Buy |
|
|||||
|
2023
Q4 | $2.5M | Buy |
|
|||||
|
2023
Q3 | $2.55M | Buy |
|
|||||
|
2023
Q2 | $3M | Buy |
|
|||||
|
2023
Q1 | $2.85M | Buy |
|
|||||
|
2022
Q4 | $834K | Sell |
|
|||||
|
2022
Q3 | $1.15M | Sell |
|
|||||
|
2022
Q2 | $1.71M | Buy |
|
|||||
|
2022
Q1 | $2.6M | Sell |
|
|||||
|
2021
Q4 | $2.69M | Buy |
|
|||||
|
2021
Q3 | $2.29M | Buy |
|
|||||
|
2021
Q2 | $2.24M | Sell |
|
|||||
|
2021
Q1 | $3.43M | Buy |
|
|||||
|
2020
Q4 | $220K | Buy |
|
|||||
|
2020
Q3 | $149K | Sell |
|
|||||
|
2020
Q2 | $141K | Hold |
|
|||||
|
2020
Q1 | $116K | Buy |
|
|||||
|
2019
Q4 | $15K | Sell |
|
|||||
|
2019
Q3 | $328K | Sell |
|
|||||
|
2019
Q2 | $530K | Buy |
|
|||||
|
2019
Q1 | $352K | Buy |
|
|||||
|
2018
Q4 | $43K | Buy |
|
|||||
|
2018
Q3 | $112K | Buy |
|
|||||
|
2018
Q2 | $50K | Sell |
|
|||||
|
2018
Q1 | $180K | Buy |
|
|||||
|
2017
Q4 | $183K | Buy |
|
|||||
|
2017
Q3 | $201K | Buy |
|
|||||
|
2017
Q2 | $212K | Sell |
|
|||||
|
2017
Q1 | $297K | Buy |
|
|||||
|
2016
Q4 | $336K | Sell |
|
|||||
|
2016
Q3 | $391K | Sell |
|
|||||
|
2016
Q2 | $841K | Hold |
|
|||||
|
2016
Q1 | $575K | Buy |
|
|||||
|
2015
Q4 | $920K | Buy |
|
|||||
|
2015
Q3 | $1.69M | Buy |
|
|||||
|
2015
Q2 | $1.15M | Buy |
|
|||||
|
2015
Q1 | $1M | Buy |
|
|||||
|
2014
Q4 | $960K | Buy |
|
|||||
|
2014
Q3 | $1.08M | Buy |
|
|||||
|
2014
Q2 | $1.27M | Buy |
|
|||||
|
2014
Q1 | $3.83M | Buy |
|
|||||
|
2013
Q4 | $1.78M | Sell |
|
|||||
|
2013
Q3 | $2.55M | Hold |
|
|||||
|
2013
Q2 | $2.7M | Buy |
|